Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide (Breuhahn et al., 2011) and represents a paradigm of inflammation-induced cancer, indicating a strong link between activation of pro-inflammatory pathways such as TNF-induced NFκB signaling and tumorigenesis. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.